Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,227) with videos related to
Page
of 123
Sort By:
Journal of Endocrinological Investigation
|
May 22, 2019
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M Caprio, M Infante, E Moriconi, et al.
Frontiers in Pediatrics
|
May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
Luca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Immunology
|
November 2, 2023
Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease
Charlotte de Fays, Vincent Geudens, Iwein Gyselinck, et al.
European Urology
|
May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
Adam Sharp, Jon C Welti, Maryou B K Lambros, et al.
Oncotarget
|
November 8, 2017
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis
Francesca Palandri, Giuseppe Alberto Palumbo, Massimiliano Bonifacio, et al.
Genes and Immunity
|
August 26, 2011
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
A Carvalho, C Cunha, A J Almeida, et al.
Seminars in Hematology
|
December 4, 2018
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study<sup>⁎</sup>
Francesca Palandri, Giuseppe A Palumbo, Alessandra Iurlo, et al.
Haematologica
|
September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Cancer Research
|
November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer
Veronica Gil, Susana Miranda, Ruth Riisnaes, et al.
European Urology
|
November 12, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
Antje Neeb, Nicolás Herranz, Sara Arce-Gallego, et al.
Page
of 123
Search research articles
Search
Showing results (1201-1210 of 1,227) with videos related to
Sort By:
Page
of 123
Journal of Endocrinological Investigation
|
May 22, 2019
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M Caprio, M Infante, E Moriconi, et al.
Frontiers in Pediatrics
|
May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
Luca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Immunology
|
November 2, 2023
Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease
Charlotte de Fays, Vincent Geudens, Iwein Gyselinck, et al.
European Urology
|
May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
Adam Sharp, Jon C Welti, Maryou B K Lambros, et al.
Oncotarget
|
November 8, 2017
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis
Francesca Palandri, Giuseppe Alberto Palumbo, Massimiliano Bonifacio, et al.
Genes and Immunity
|
August 26, 2011
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
A Carvalho, C Cunha, A J Almeida, et al.
Seminars in Hematology
|
December 4, 2018
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study<sup>⁎</sup>
Francesca Palandri, Giuseppe A Palumbo, Alessandra Iurlo, et al.
Haematologica
|
September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Cancer Research
|
November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer
Veronica Gil, Susana Miranda, Ruth Riisnaes, et al.
European Urology
|
November 12, 2020
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
Antje Neeb, Nicolás Herranz, Sara Arce-Gallego, et al.
Page
of 123